Cargando…

Circulating miR-3659 may be a potential biomarker of dyslipidemia in patients with obesity

BACKGROUND: The present study attempted to identify potential key genes and miRNAs of dyslipidemia in obese, and to investigate the possible mechanisms associated with them. METHODS: The microarray data of GSE66676 were downloaded, including 67 obese samples from the Gene Expression Omnibus (GEO) da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Liu, Yin, Rui-Xing, Pan, Shang-Ling, Yang, Shuo, Yang, De-Zhai, Lin, Wei-Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332685/ https://www.ncbi.nlm.nih.gov/pubmed/30642348 http://dx.doi.org/10.1186/s12967-019-1776-8

Ejemplares similares

Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
por: Chang, Yu-Hsiang, et al.
Publicado: (2023)

BCL3-PVRL2-TOMM40 SNPs, gene-gene and gene-environment interactions on dyslipidemia
por: Miao, Liu, et al.
Publicado: (2018)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer
por: Byun, Young Joon, et al.
Publicado: (2021)

Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease
por: Zhang, Xiong, et al.
Publicado: (2017)

Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone
por: Kang, Ho Won, et al.
Publicado: (2022)

Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015)

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
por: Salvoza, Noel C., et al.
Publicado: (2016)

Circulating miR-216a as a biomarker of metabolic alterations and obesity in women
por: Vonhögen, Indira G.C., et al.
Publicado: (2020)

Correction: Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015)

Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer
por: Liu, Xiangxiang, et al.
Publicado: (2019)

miR-129-5p Inhibits Adipogenesis through Autophagy and May Be a Potential Biomarker for Obesity
por: Fu, Xue, et al.
Publicado: (2019)

miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
por: Ivo D’Urso, Pietro, et al.
Publicado: (2015)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism
por: Chen, Yao-ping, et al.
Publicado: (2016)

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer
por: Torbati, Peyman Mohammadi, et al.
Publicado: (2019)

Association of Plasma MiR-17-92 With Dyslipidemia in Patients With Coronary Artery Disease
por: Liu, Fengqiong, et al.
Publicado: (2014)

Draft Genome Sequence of Pseudomonas sp. Strain MWU13-3659, Isolated from Commercial Cranberry Bog Soil in Massachusetts, USA
por: Kooner, Amritpal, et al.
Publicado: (2022)

Downregulation of Circulating Hsa-miR-200c-3p Correlates with Dyslipidemia in Patients with Stable Coronary Artery Disease
por: Vancheri, Chiara, et al.
Publicado: (2023)

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
por: Redova, Martina, et al.
Publicado: (2012)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
por: Copier, Camila Uribe, et al.
Publicado: (2017)

Circulating miR-15a and miR-222 as Potential Biomarkers of Type 2 Diabetes
por: Sadeghzadeh, Salman, et al.
Publicado: (2020)

Association between the MVK and MMAB polymorphisms and serum lipid levels
por: Miao, Liu, et al.
Publicado: (2017)

Circulating miR-765 and miR-149: Potential Noninvasive Diagnostic Biomarkers for Geriatric Coronary Artery Disease Patients
por: Ali Sheikh, Md Sayed, et al.
Publicado: (2015)

Circulating miRNAs in girls with abdominal obesity: miR‐221‐3p as a biomarker of response to weight loss interventions
por: Ojeda‐Rodríguez, Ana, et al.
Publicado: (2022)

Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer
por: Ourô, Susana, et al.
Publicado: (2020)

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013)

Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
por: Du, Mulong, et al.
Publicado: (2015)

MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability
por: Singh, Sandeep, et al.
Publicado: (2020)

Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)

Clinical value of serum miR-1-3p as a potential circulating biomarker for abdominal aortic aneurysm
por: Jing, Jingjing, et al.
Publicado: (2023)

Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
por: Perilli, Lisa, et al.
Publicado: (2014)

Association between serum oestradiol level on the hCG administration day and neonatal birthweight after IVF-ET among 3659 singleton live births
por: Liu, Yu, et al.
Publicado: (2021)

Traditional Chinese Medicine Intervenes Ventricular Remodeling Following Acute Myocardial Infarction: Evidence From 40 Random Controlled Trials With 3,659 Subjects
por: Zhang, Xiao-Xiao, et al.
Publicado: (2021)

Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer
por: Zhang, Jingpu, et al.
Publicado: (2015)

Higher expression of circulating miR-182 as a novel biomarker for breast cancer
por: WANG, PING-YU, et al.
Publicado: (2013)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022)

Circulating miR-185 might be a novel biomarker for clinical outcome in patients with dilated cardiomyopathy
por: Yu, Miao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_64qap46s6nfp20p2io00q2c0c9